UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
______________

FORM 8-K
______________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):
December 8, 2015

USANA HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)

Utah
(State or other jurisdiction of incorporation)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01       Other Events.                 

On December 8, 2015, USANA Health Sciences, Inc. (the “Company”), issued a press release announcing that its Board of Directors has authorized an additional $100 million in funding for share repurchases by the Company of its outstanding common stock.  The Company also disclosed in the release that, as of December 4, 2015, the Company has repurchased approximately 456,790 shares during the fourth quarter of 2015 for a total investment of $61.2 million, which completes the Board of Directors’ previous share repurchase authorization.  A copy of the press release is furnished herewith as Exhibit 99 to this Current Report on Form 8-K and is incorporated herein by reference.  The Company will also post the press release, along with this Form 8-K, on its corporate website, www.usanahealthsciences.com.  

Item 9.01       Financial Statements and Exhibits.

                        (d)  Exhibits

Exhibit 99      Press release issued by USANA Health Sciences, Inc. dated December 8, 2015 (furnished herewith).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.